gene therapy - search results

MyBones explores the potential Low-intensity Vibration therapy has as a natural alternative to prevent and combat osteoporosis.

The Imaging and Radiation Oncology Core is part of the U.S. National Cancer Institute’s clinical trial program and provides quality assurance for trials with radiation oncology and/or imaging.

Pascale V Guillot, at the University College London, looks toward improving the quality of life for those with Osteogenesis imperfecta, a chronic health condition called brittle bone disease.

People who undergo Gender Affirming Hormone Therapy have high grades of satisfaction with the physical and psychological effects – and have fewer suicidal thoughts.

Stefaan Van Gool, MD, PhD brings to light the important role of Individualised Multimodal Immunotherapy in improving the survival of brain cancer.

CEO of Brittle Bone Society Patricia Osborne, revisits aspects of the condition and shares what is known around current medical research and treatments, speaking to experts attached to the Charity.

Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.

Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.

Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.

New research suggests that in suppressing a mutated ALS gene, it may be possible to delay to onset of symptoms.

Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field

Professor Olivier Braissant, believes there is hope for the treatment of creatine deficiency thanks to new genetic disease research - here, he tells us all about the recent developments.

A new study shows promise for future therapies for blinding eye diseases, uveitis and multiple sclerosis.

Australia has committed to investing heavily in its medical future – but will it be ready for the regenerative medicine revolution? John Gardner from Monash University and Michael Morrison from the University of Oxford provide the answer.

Pascale V Guillot from Elizabeth Garrett Anderson Institute for Women’s Health, provides further analysis of stem cell therapy for brittle bone disease

Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy

Dr Deborah Lee, Dr Fox Online Pharmacy, discusses the link between menopause and type-2 diabetes, as well as the use of hormone replacement therapy (HRT) in diabetic perimenopausal women Doctors have been reluctant in the past, to prescribe hormone replacement therapy (HRT) for perimenopausal women with type-2 diabetes (T2DM). This...

Frost & Sullivan’s TechCasting Group, places the spotlight on osteogenesis imperfecta – toward future targeted, more effective therapy.

This article focuses on Japan, as a country with a strong and distinctive strategy for delivering RM, and outlines efforts to build regenerative readiness.

Patricia Osborne, Chief Executive of the Brittle Bone Society, tells us what we need to know about Osteogenesis Imperfecta.